Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer
- Autores
- Prack Mc Cormick, Bárbara Patricia; Langle, Yanina Verónica; Belgorosky, Denise; Vanzulli, Silvia; Balarino, Natalia Patricia; Sandes, Eduardo Omar; Eijan, Ana Maria
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Conservative treatment for invasive bladder cancer (BC) involves a complete transurethral tumor resection combined with chemotherapy (CT) and radiotherapy (RT). The major obstacles of chemo-radiotherapy are the addition of the toxicities of RT and CT, and the recurrence due to RT and CT resistances. The flavonoid Silybin (Sb) inhibits pathways involved in cell survival and resistance mechanisms, therefore the purpose of this paper was to study in vitro and in vivo, the ability of Sb to improve the response to RT, in two murine BC cell lines, with different levels of invasiveness, placing emphasis on radio-sensitivity, and pathways involved in radio-resistance and survival. In vitro, Sb radio-sensitized murine invasive cells through the inhibition of RT-induced NF-κB and PI3K pathways, and the increase of oxidative stress, while non-invasive cells did not show to be sensitized. In vivo, Sb improved RT-response and overall survival in invasive murine tumors. As Sb is already being tested in clinical trials for other urological cancers and it improves RT-response in invasive BC, these results could have translational relevance, supporting further research.
Fil: Prack Mc Cormick, Bárbara Patricia. Universidad Nacional de Lomas de Zamora. Facultad de Cs.agrarias. Laboratorio de Suelos; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Langle, Yanina Verónica. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina
Fil: Belgorosky, Denise. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina
Fil: Vanzulli, Silvia. Academia Nacional de Medicina de Buenos Aires; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina
Fil: Balarino, Natalia Patricia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sandes, Eduardo Omar. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina
Fil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
BLADDER CANCER
BLADDER PRESERVATION
SILYBIN
RADIOTHERAPY
RADIOSENSITIZER - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/93289
Ver los metadatos del registro completo
id |
CONICETDig_894bdd73f745ab2050292d4f7ea437c5 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/93289 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancerPrack Mc Cormick, Bárbara PatriciaLangle, Yanina VerónicaBelgorosky, DeniseVanzulli, SilviaBalarino, Natalia PatriciaSandes, Eduardo OmarEijan, Ana MariaBLADDER CANCERBLADDER PRESERVATIONSILYBINRADIOTHERAPYRADIOSENSITIZERhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Conservative treatment for invasive bladder cancer (BC) involves a complete transurethral tumor resection combined with chemotherapy (CT) and radiotherapy (RT). The major obstacles of chemo-radiotherapy are the addition of the toxicities of RT and CT, and the recurrence due to RT and CT resistances. The flavonoid Silybin (Sb) inhibits pathways involved in cell survival and resistance mechanisms, therefore the purpose of this paper was to study in vitro and in vivo, the ability of Sb to improve the response to RT, in two murine BC cell lines, with different levels of invasiveness, placing emphasis on radio-sensitivity, and pathways involved in radio-resistance and survival. In vitro, Sb radio-sensitized murine invasive cells through the inhibition of RT-induced NF-κB and PI3K pathways, and the increase of oxidative stress, while non-invasive cells did not show to be sensitized. In vivo, Sb improved RT-response and overall survival in invasive murine tumors. As Sb is already being tested in clinical trials for other urological cancers and it improves RT-response in invasive BC, these results could have translational relevance, supporting further research.Fil: Prack Mc Cormick, Bárbara Patricia. Universidad Nacional de Lomas de Zamora. Facultad de Cs.agrarias. Laboratorio de Suelos; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Langle, Yanina Verónica. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; ArgentinaFil: Belgorosky, Denise. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; ArgentinaFil: Vanzulli, Silvia. Academia Nacional de Medicina de Buenos Aires; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; ArgentinaFil: Balarino, Natalia Patricia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Sandes, Eduardo Omar. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; ArgentinaFil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaWiley-liss, Div John Wiley & Sons Inc2018-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/93289Prack Mc Cormick, Bárbara Patricia; Langle, Yanina Verónica; Belgorosky, Denise; Vanzulli, Silvia; Balarino, Natalia Patricia; et al.; Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer; Wiley-liss, Div John Wiley & Sons Inc; Journal of Cellular Biochemistry; 119; 7; 1-2018; 5402-54120730-2312CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26693info:eu-repo/semantics/altIdentifier/doi/10.1002/jcb.26693info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:23:05Zoai:ri.conicet.gov.ar:11336/93289instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:23:06.132CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
title |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
spellingShingle |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer Prack Mc Cormick, Bárbara Patricia BLADDER CANCER BLADDER PRESERVATION SILYBIN RADIOTHERAPY RADIOSENSITIZER |
title_short |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
title_full |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
title_fullStr |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
title_full_unstemmed |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
title_sort |
Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer |
dc.creator.none.fl_str_mv |
Prack Mc Cormick, Bárbara Patricia Langle, Yanina Verónica Belgorosky, Denise Vanzulli, Silvia Balarino, Natalia Patricia Sandes, Eduardo Omar Eijan, Ana Maria |
author |
Prack Mc Cormick, Bárbara Patricia |
author_facet |
Prack Mc Cormick, Bárbara Patricia Langle, Yanina Verónica Belgorosky, Denise Vanzulli, Silvia Balarino, Natalia Patricia Sandes, Eduardo Omar Eijan, Ana Maria |
author_role |
author |
author2 |
Langle, Yanina Verónica Belgorosky, Denise Vanzulli, Silvia Balarino, Natalia Patricia Sandes, Eduardo Omar Eijan, Ana Maria |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
BLADDER CANCER BLADDER PRESERVATION SILYBIN RADIOTHERAPY RADIOSENSITIZER |
topic |
BLADDER CANCER BLADDER PRESERVATION SILYBIN RADIOTHERAPY RADIOSENSITIZER |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Conservative treatment for invasive bladder cancer (BC) involves a complete transurethral tumor resection combined with chemotherapy (CT) and radiotherapy (RT). The major obstacles of chemo-radiotherapy are the addition of the toxicities of RT and CT, and the recurrence due to RT and CT resistances. The flavonoid Silybin (Sb) inhibits pathways involved in cell survival and resistance mechanisms, therefore the purpose of this paper was to study in vitro and in vivo, the ability of Sb to improve the response to RT, in two murine BC cell lines, with different levels of invasiveness, placing emphasis on radio-sensitivity, and pathways involved in radio-resistance and survival. In vitro, Sb radio-sensitized murine invasive cells through the inhibition of RT-induced NF-κB and PI3K pathways, and the increase of oxidative stress, while non-invasive cells did not show to be sensitized. In vivo, Sb improved RT-response and overall survival in invasive murine tumors. As Sb is already being tested in clinical trials for other urological cancers and it improves RT-response in invasive BC, these results could have translational relevance, supporting further research. Fil: Prack Mc Cormick, Bárbara Patricia. Universidad Nacional de Lomas de Zamora. Facultad de Cs.agrarias. Laboratorio de Suelos; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Langle, Yanina Verónica. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina Fil: Belgorosky, Denise. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina Fil: Vanzulli, Silvia. Academia Nacional de Medicina de Buenos Aires; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina Fil: Balarino, Natalia Patricia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Sandes, Eduardo Omar. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina Fil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Conservative treatment for invasive bladder cancer (BC) involves a complete transurethral tumor resection combined with chemotherapy (CT) and radiotherapy (RT). The major obstacles of chemo-radiotherapy are the addition of the toxicities of RT and CT, and the recurrence due to RT and CT resistances. The flavonoid Silybin (Sb) inhibits pathways involved in cell survival and resistance mechanisms, therefore the purpose of this paper was to study in vitro and in vivo, the ability of Sb to improve the response to RT, in two murine BC cell lines, with different levels of invasiveness, placing emphasis on radio-sensitivity, and pathways involved in radio-resistance and survival. In vitro, Sb radio-sensitized murine invasive cells through the inhibition of RT-induced NF-κB and PI3K pathways, and the increase of oxidative stress, while non-invasive cells did not show to be sensitized. In vivo, Sb improved RT-response and overall survival in invasive murine tumors. As Sb is already being tested in clinical trials for other urological cancers and it improves RT-response in invasive BC, these results could have translational relevance, supporting further research. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/93289 Prack Mc Cormick, Bárbara Patricia; Langle, Yanina Verónica; Belgorosky, Denise; Vanzulli, Silvia; Balarino, Natalia Patricia; et al.; Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer; Wiley-liss, Div John Wiley & Sons Inc; Journal of Cellular Biochemistry; 119; 7; 1-2018; 5402-5412 0730-2312 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/93289 |
identifier_str_mv |
Prack Mc Cormick, Bárbara Patricia; Langle, Yanina Verónica; Belgorosky, Denise; Vanzulli, Silvia; Balarino, Natalia Patricia; et al.; Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer; Wiley-liss, Div John Wiley & Sons Inc; Journal of Cellular Biochemistry; 119; 7; 1-2018; 5402-5412 0730-2312 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26693 info:eu-repo/semantics/altIdentifier/doi/10.1002/jcb.26693 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley-liss, Div John Wiley & Sons Inc |
publisher.none.fl_str_mv |
Wiley-liss, Div John Wiley & Sons Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842981273727926272 |
score |
12.493442 |